Précédent|Prochain

Impact de RARRES2 sur le métabolisme des lipides dans le cancer du sein triple négatif : une voie vers les métastases cérébrales

  • role： Corresponding author, First author通信作者, 第一作者
  • Affiliation：

    Institute of Chemistry, University of Silesia in Katowice, 41-500 Chorzów, Poland

    Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China

  • Email：tanminul-haque-shubra.quazi@us.edu.pl
  • Introduction：*tanminul-haque-shubra.quazi@us.edu.pl; shubhro.du@gmail.com
Quazi T. H. Shubhra12*

résumé

mots-clés

Retinoic acid receptor responder 2 (RARRES2);Lipid metabolism;Cancer;PTEN-mTOR-SREBP1 signaling;Metabolic reprogramming;Brain metastasis

References

  1. 1..
    Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, et al. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Mil Med Res. 2023;10(1):34.
  2. 2..
    Guo K, Xiao N, Liu Y, Wang Z, Tóth J, Gyenis J, et al. Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: opportunities and challenges. Nano Mater Sci. 2022;4(4):295–321.
  3. 3..
    Sirhan Z, Thyagarajan A, Sahu RP. The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer. Mil Med Res. 2022;9(1):39.
  4. 4..
    Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab. 2010;21(11):660–7.
  5. 5..
    Rennier K, Shin WJ, Krug E, Virdi G, Pachynski RK. Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via modulation of a novel CMKLR1-mediated signaling cascade. Clin Cancer Res. 2020;26(18):5019–35.

Lire l'article complet

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website